Business Daily cover image

Denmark and the Novo Nordisk effect

Business Daily

00:00

The Rise of GLP-1 Drugs in Anti-Obesity Market

Exploring Novo Nordisk's success in producing cutting-edge GLP-1 drugs for obesity treatment, touching upon the challenges faced by the company and the industry's response to global demand for diabetes and obesity solutions.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app